IPOPLUS

13.56

+1.69 +14.24%

16 Jun 2026

NSE Listed · Pharmaceuticals

Nectar Lifesciences Ltd. (NECLIFE)

Volume: 4,130Avg Vol 1W: 22,575Avg Vol 1M: 22,12352W Range:9.328.25
₹13.56 14.24%
Market Cap₹229 Cr
Current Price₹13.56
Previous Close₹11.87
High / Low (52w)₹28.25 / ₹9.3
Volume4,130
Avg Vol (1W)22,575
Avg Vol (1M)22,123
Stock P/E
Book Value₹25.96
Dividend Yield0%
ROE-9.85%
ROA-47.12%
Revenue (TTM)
Revenue Growth-0.84%
Profit Margin-47.62%
Total Debt₹60 Cr
Shares Outstanding19 Cr
Face Value₹1
EPS (TTM)₹-3.38
P/B0.52
Debt / Equity0
50 DMA₹12.4
200 DMA₹13.07
Day change+14.24%
Price Chart
11.71 17.01% · 1Y
2295.1Cr
2025-10-01
2026-06-16

20-day avg volume: 21K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1 Cr₹0 Cr₹1 Cr₹5 Cr₹0 Cr₹0 Cr₹6 Cr₹359 Cr₹441 Cr₹452 Cr₹398 Cr₹394 Cr₹389 Cr₹344 Cr₹389 Cr₹403 Cr₹476 Cr₹443 Cr₹365 Cr₹385 Cr₹349 Cr₹378 Cr₹428 Cr₹390 Cr₹565 Cr
EBITDA₹-51 Cr₹-1 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹25 Cr₹35 Cr₹27 Cr₹22 Cr₹21 Cr₹21 Cr₹0 Cr₹-11 Cr₹27 Cr₹35 Cr₹33 Cr₹18 Cr₹26 Cr₹15 Cr₹18 Cr₹17 Cr₹2 Cr₹39 Cr
Net Profit₹-68 Cr₹14 Cr₹-176 Cr₹-63 Cr₹-130 Cr₹8 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹4 Cr₹-9 Cr₹-22 Cr₹4 Cr₹12 Cr₹10 Cr₹2 Cr₹2 Cr₹-41 Cr₹-8 Cr₹-7 Cr₹-17 Cr₹7 Cr
EPS-3.380.64-7.85-2.82-5.80.350.250.130.030.070.050.080.16-0.41-10.170.520.430.080.08-1.83-0.36-0.33-0.750.33
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,675 Cr₹1,699 Cr₹1,567 Cr₹1,680 Cr₹1,547 Cr₹2,371 Cr
EBITDA₹-87 Cr₹105 Cr₹37 Cr₹113 Cr₹53 Cr₹163 Cr
Net Profit₹-114 Cr₹5 Cr₹-24 Cr₹25 Cr₹-73 Cr₹32 Cr
EPS-5.070.22-1.081.12-3.271.42
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹2,047 Cr₹2,191 Cr₹2,189 Cr₹2,391 Cr₹2,471 Cr₹2,633 Cr
Total Liabilities₹1,091 Cr₹1,122 Cr₹1,125 Cr₹1,303 Cr₹1,409 Cr₹1,497 Cr
Equity₹956 Cr₹1,069 Cr₹1,065 Cr₹1,088 Cr₹1,062 Cr₹1,136 Cr
Total Debt₹60 Cr₹140 Cr₹226 Cr₹291 Cr₹128 Cr₹121 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹169 Cr₹225 Cr₹134 Cr₹95 Cr₹25 Cr₹294 Cr
Investing₹-42 Cr₹-17 Cr₹52 Cr₹17 Cr₹-29 Cr₹-33 Cr
Financing₹-128 Cr₹-205 Cr₹-186 Cr₹-119 Cr₹11 Cr₹-252 Cr
Free Cash Flow₹169 Cr₹225 Cr₹134 Cr₹95 Cr₹25 Cr₹294 Cr
Shareholding
Promoter 51.84% Institutions 4.62% Public 43.52%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search